No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
REKR240517P2000
- 0.40
- +0.05+14.29%
15min DelayClose May 14 15:59 ET
0.45High0.40Low
0.45Open0.35Pre Close2 Volume509 Open Interest2.00Strike Price85.00Turnover261.33%IV-3.32%PremiumMay 17, 2024Expiry Date0.35Intrinsic Value100Multiplier3DDays to Expiry0.06Time Value100Contract SizeAmericanOptions Type-0.7424Delta0.7985Gamma4.14Leverage Ratio-0.0208Theta-0.0001Rho-3.07Eff Leverage0.0005Vega
Intraday
- 5D
- 1D
News
While Institutions Own 29% of Rekor Systems, Inc. (NASDAQ:REKR), Individual Investors Are Its Largest Shareholders With 46% Ownership
Rekor Systems to Announce First Quarter Fiscal 2024 Results
Company will host earnings call on Wednesday, May 15, 2024COLUMBIA, MD / ACCESSWIRE / April 22, 2024 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor" or the "Company"), a leader in developing and implemen
12 Information Technology Stocks Moving In Friday's After-Market Session
GainersARB IOT Group (NASDAQ:ARBB) shares increased by 11.9% to $1.32 during Friday's after-market session. The company's market cap stands at $34.8 million. Quantum (NASDAQ:QMCO) shares moved upwards
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
GainersMicroCloud Hologram (NASDAQ:HOLO) stock increased by 48.7% to $3.33 during Thursday's pre-market session. The market value of their outstanding shares is at $19.7 million. Verb Tech (NASDAQ:VER
12 Information Technology Stocks Moving In Wednesday's After-Market Session
GainersMarin Software (NASDAQ:MRIN) shares moved upwards by 5.3% to $0.29 during Wednesday's after-market session. The market value of their outstanding shares is at $5.3 million. Sprinklr (NYSE:CXM)
Understanding the Risks: Navigating Rekor Systems' Stock Volatility in a Fluctuating Market
Comments
I have noticed recently that some shares despite FDA approval, price action is opposite, also earning call sometimes when it beats estimates projection, the market sentiment or price action is in reverse.
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
Which is more important when picking a trade:
Earning or FDA outcome
Acquisition or Market sentiment
Happy to learn from friends here.
$Enlivex Therapeutics(ENLV.US$
$Akebia Therapeutics(AKBA.US$
$Rekor Systems(REKR.US$
$OncoCyte(OCX.US$
1
2
$Akebia Therapeutics(AKBA.US$
I am seeing a similar trend with $Rekor Systems(REKR.US$
Shorties will keep it down for ever.
Will average down on this. What do you think guys?
I am seeing a similar trend with $Rekor Systems(REKR.US$
Shorties will keep it down for ever.
Will average down on this. What do you think guys?
2
4
$Rekor Systems (REKR.US)$ all good news for rekor but yet the stock price is tanking. such bullshit
3
$Rekor Systems(REKR.US$ time to buy!!!
1
Rekor Systems' high P/S ratio is likely due to investors' expectations of continued strong revenue performance. The potential for a deterioration in revenues is seen as remote, justifying the elevated P/S ratio.
1
Read more
101674396 : May chance to drop to 1 or below
stockhubOP 101674396: Unpredictable. Earning report might change the plan